Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Abstract Background Survival rates for lymphoma are highest amongst hematological malignancies. In 2019, it was estimated that over 6400 Australians were diagnosed with lymphoma, a group of hematological malignancies with a high 5-year survival rate of ~ 76%. There is an increased focus on the promo...

Full description

Bibliographic Details
Main Authors: Raymond Javan Chan, Stephanie Buhagiar, Laisa Teleni, Camilla Simonsen, Jane Turner, Courtney Rawson, Nicolas H. Hart, Lee Jones, Louisa Gordon, Ria Joseph, Oluwaseyifunmi Andi Agbejule, Fiona Henderson, Joel Rhee, Marissa Ryan, Christine Carrington, Sally Mapp
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Trials
Subjects:
Lymphoma
Hematology
Shared care
Quality of life
Protocol
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-020-04945-4

Internet

https://doi.org/10.1186/s13063-020-04945-4

Similar Items